


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-2.13%
+0.69%
-2.08%
+0.82%
-8.52%
GMED
Globus Medical
$88.65
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market
GMED Price Performance
$83.89 (+5.67%)
$56.22 (+57.68%)
$57.55 (+54.04%)
$81.94 (+8.19%)
GMED has Fair risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

GMED overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
GMED Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
GMED Street Sentiment is extremely bullish and have positive views on the near-term outlook
What is GMED current stock price?
What are GMED stock strengths?
What is GMED Risk Level?
What is GMED market cap and volume?
What is GMED current Stock IQ?
Should I buy GMED stock right now?
Is GMED a Strong Buy right now?
What does a 'Strong Buy' rating mean for GMED?
What does a 'Strong Sell' rating mean for GMED?
What factors influence GMED's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-2.13%
+0.69%
-2.08%
+0.82%
-8.52%
GMED
Globus Medical
Current Price
$88.65
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market

GMED Price Performance
$83.89 (+5.67%)
$56.22 (+57.68%)
$57.55 (+54.04%)
$81.94 (+8.19%)
GMED Analysts Opinion
GMED Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
GMED Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
GMED Street Sentiment is extremely bullish and have positive views on the near-term outlook
GMED has Fair risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

GMED Stock IQ
GMED Latest Analysis
Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term. Wondering how to pick strong market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Thu Dec 4, 2025
Is Globus Medical (GMED) a Solid Growth Stock? 3 Reasons to Think &.Yes&.. Globus Medical (GMED) could produce exceptional returns because of its solid growth attributes.
Wed Dec 3, 2025
Morgan Stanley Maintains Globus Medical (GMED) Overweight Recommendation. Fintel reports that on December 2 2025 Morgan Stanley maintained coverage of Globus Medical (NYSE:GMED) with a Overweight recommendation. Analyst Price Forecast Suggests 1.00% Upside
Wed Dec 3, 2025
Should You Buy Globus Medical (GMED) After Golden Cross?. When a stock experiences a golden cross technical event good things could be on the horizon. How should investors react?
Mon Nov 24, 2025
Truist Securities Reiterates Globus Medical (GMED) Buy Recommendation. Fintel reports that on November 18 2025 Truist Securities reiterated coverage of Globus Medical (NYSE:GMED) with a Buy recommendation. Analyst Price Forecast Suggests 8.43% Upside
Wed Nov 19, 2025
Globus Medical (GMED) Price Target Increased by 10.72% to 90.69. The average one-year price target for Globus Medical (NYSE:GMED) has been revised to $90.69 / share. This is an increase of 10.72% from the prior estimate of $81.91 dated November 7 2025. The price target is an average of many targets provided by analysts. Th
Tue Nov 18, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
GMED Stock trends
GMED Stock performance
GMED Stock analysis
GMED investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.